Caliper Life Sciences Closes Multiple LabChip and IVIS Sales at Top Pharma and Biotech Companies
News Dec 13, 2006
These systems will help scientists to accelerate and improve drug discovery and development.
Caliper's LabChip and IVIS systems are designed to connect research data from in vitro experimentation to in vivo experimentation. By connecting in vivo and in vitro experimentation, researchers are able to predict human outcomes and reduce drug candidate attrition.
Caliper's portfolio of offerings provides the pharmaceutical industry with the technology and support to improve clinical relevance and develop effective treatments for disease.
"With the Caliper name supporting the IVIS imaging system, we are seeing rapid adoption in the commercial sector," said Kevin Hrusovsky, CEO of Caliper Life Sciences.
“The sales of both products are representative of Caliper's ability to meet the needs and demands of the industry while fostering the company's own growth and strategic direction as a leading provider of in vitro and in vivo drug discovery and development technologies."
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE